Trial Profile
Post-authorization open-label study in knee osteoarthritis patients receiving chondroitin sulfate 800 mg daily during 6 months
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Chondroitin sulfate (Primary)
- Indications Osteoarthritis
- Focus Pharmacodynamics
- Sponsors Bioiberica
- 06 Oct 2015 New trial record